Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

por Huhn, S, Weinhold, N, Nickel, J, Pritsch, M, Hielscher, T, Hummel, M, Bertsch, U, Huegle-Doerr, B, Vogel, M, Angermund, R, Hänel, M, Salwender, H J, Weisel, K, Dürig, J, Görner, M, Kirchner, H, Peter, N, Graeven, U, Lordick, F, Hoffmann, M, Reimer, P, Blau, I W, Jauch, A, Dembowsky, K, Möhler, T, Wuchter, P, Goldschmidt, H
Publicado 2017